If you can see this message, your browser does not support canvas and needs an update. Sorry. :(
Friday, September 21, 2018 
Market Status: CLOSE
About us and Governance Investor Relations Contact
Advanced search

Market News


ZENTIVA S.A. - SCD

Additional report on transactions with affiliates

Release Date: 2/19/2018 6:22:34 PM

IRIS Code: 0E135

Current Raport

 

Current Report according            - art. 82 from Law no. 24/2017 and art. 113 from  Regulation  no.1/2006                                               

Date of the report:                         -19.02.2018

Name of the issuer                        - S.C. ZENTIVA S.A.

Main seat:                                       - Bd. Theodor Pallady nr.50, Bucuresti

Tel. /Fax no.:                                   -  021-3047200 /021-345.40.04

Unique Code:                                  - 336206                                 

Registration No.                              - J/40/363/1991

Shared capital                                  - 41.696.115 RON           

Capital market                                  - Bucharest Stock Exchange

 

Significant events to be reported:

 

 

1. With regard to the current reports Zentiva S.A. informed in relation to the conclusion with Sanofi Romania SRL, on September 1, 2009, of some frame promotional/administrative services agreements and a supply agreement of medicines, on 26.09.2011, Zentiva SA informs:

 

(i) The cumulated value of the frame agreements regarding the promotional/administrative services provided by Zentiva SA to Sanofi Romania SRL through its sales force, employees/providers in relation to its operations (selling of pharmaceutical products), during the year 2017, is 3.784.646 RON.

 

(ii) The cumulated value of the frame agreements regarding the promotional/administrative services provided by Sanofi Romania SRL to Zentiva SA through its sales force, employees/providers in relation to its operations (selling of pharmaceutical products), during the year 2017, is 10.157.335RON.

 

(iii) The value of the supply agreement Zerntiva SA delivers to Sanofi Romania SRL medicines, during the year 2017, is 254.153.143 RON.

 

As per the available internal accounting data, at the date of the present current report, the value of the mutual receivables are:

- Zentiva SA receivables to be received from Sanofi Romania SRL : 86.038.274 RON;

- Sanofi Romania SRL receivables to be received from Zentiva SA :       72.246 RON.

 

 

2. With regard to the current report Zentiva S.A. informed in relation to the conclusion with Zentiva a.s. of two frame services agreements on 19.04.2014, covering promotional services, respectively  regulatory services, provided by Zentiva SA to Zentiva a.s. in relation to the selling on the Romanian market of pharmaceutical products belonging to other group entities, Zentiva SA informs:

 

(i) The cumulated value of the frame agreements regarding the promotional services, respectively  regulatory services, provided by Zentiva SA to Zentiva a.s. in relation to the selling on the Romanian market of pharmaceutical products belonging to other group entities, during the year 2017, is 789.413 RON.

 

As per the available internal accounting data, at the date of the present current report, the value of the mutual receivables are:

- Zentiva SA receivables to be received from Zentiva a.s. : 111.958 RON;

- Zentiva a.s receivables to be received from Zentiva SA :              0 RON.

 

3. With regard to the current report dated 13.10.2010, Zentiva S.A. informed in relation to the conclusion with ECZACIBASI-ZENTIVA SAGLIK URUNLERI VE TICARET A.S.of a supply agreement of medicines based on which Zentiva SA acquires medicines, Zentiva SA informs:

 

(i) The cumulated value of the supply agreement, during the year 2017, is 3.459.334 RON.

 

As per the available internal accounting data, at the date of the present current report, the value of the mutual receivables are:

- Zentiva SA receivables to be received from ECZACIBASI-ZENTIVA SAGLIK URUNLERI VE TICARET A.S.: 1.030.759 RON;

- ECZACIBASI-ZENTIVA SAGLIK URUNLERI VE TICARET A.S.receivables to be received from Zentiva SA :              0 RON.

 

4. With regard to the current reports dated 27.09.2011, 10.04.2012 and 02.02.2017, Zentiva S.A. informed in relation to the conclusion with Sanofi Wintrop Industrie of a frame services agreement and a license and supply agreements of medicines, Zentiva SA informs:

 

(i) The value of the frame services agreement regarding the promotional, consultancy, regulatory and other services provided by Zentiva SA to Sanofi Wintrop Industrie in relation to the selling on the Romanian market of the Zentiva drugs belonging to other entities from the group, during the year 2017, is 21.491.160 RON.

 

(ii) The cumulated value of the license and supply agreements of medicines, during the year 2017, is 132.722.813 RON.

 

As per the available internal accounting data, at the date of the present current report, the value of the mutual receivables are:

- Zentiva SA receivables to be received from Sanofi Wintrop Industrie: 37.301.589 RON;

- Sanofi Wintrop Industrie receivables to be received from Zentiva SA :      940.766 RON.

 

5. With regard to the current report dated 15.07.2013, Zentiva S.A. informed in relation to the conclusion with Sanofi India Limited of a services agreement based on which Zentiva SA provides control and release services in relation to the medicines manufactured by Sanofi India Limited, Zentiva SA informs:

 

(i) The value of the services agreement based on which Zentiva SA provides control and release services in relation to the medicines manufactured by Sanofi India Limited, during the year 2017, is 1.585.436 RON.

 

As per the available internal accounting data, at the date of the present current report, the value of the mutual receivables are:

- Zentiva SA receivables to be received from Sanofi India Limited: 850.903 RON;

- Sanofi India Limited receivables to be received from Zentiva SA :            0 RON.

 

6. With regard to the current report dated 08.06.2015, Zentiva S.A. informed in relation to the conclusion with Sanofi-Aventis Group an agreement having as object the reinvoicing to Sanofi Aventis Group of the operating costs for running a Global Procurement Support Platform, Zentiva SA informs:

 

(i) The value of the agreement, during the year 2017, is 1.832.182 RON.

 

As per the available internal accounting data, at the date of the present current report, the value of the mutual receivables are:

- Zentiva SA receivables to be received from Sanofi-Aventis Group: 490.380 RON;

- Sanofi-Aventis Group receivables to be received from Zentiva SA :           0 RON.

 

7. With regard to the current report dated 17.09.2013, Zentiva S.A. informed in relation to the conclusion with Sanofi SA a cash pooling agreement, Zentiva SA informs:

 

(i) The value of the agreement, during the year 2017, representing only interest income, is 910.643 RON.

      

In relation to the rationale of setting up the value of the agreement, please note that the capital movements specific to the cash management operations have not been considered.

 

As per the available internal accounting data, at the date of the present current report, the value of the mutual receivables are:

- Zentiva SA receivables to be received from Sanofi SA: 0 RON;

- Sanofi SA receivables to be received from Zentiva SA :0 RON.

 

8. With regard to the license agreement concluded with Zentiva Group a.s. on January 1, 2009 and the framework services agreement concluded with Zentiva Group a.s. on September 22, 2008, Zentiva SA informs:

 

(i) The cumulated value of both agreements, during the year 2017, is 16.678.258 RON.

           

As per the available internal accounting data, at the date of the present current report, the value of the mutual receivables are:

- Zentiva SA receivables to be received from Zentiva Group a.s.:              0 RON;

- Zentiva Group a.s.receivables to be received from Zentiva SA:  1.971.236 RON.

 

9. With regard to the frame services agreement concluded with Zentiva k.s. on June 1, 2009 regarding the regulatory services provided by Zentiva SA to Zentiva k.s. in relation to Zentiva products belonging to other group entities, Zentiva SA informs:

 

(i) The value of the agreement, during the year 2017, is 52.903 RON.

           

As per the available internal accounting data, at the date of the present current report, the value of the mutual receivables are:

- Zentiva SA receivables to be received from Zentiva k.s.:        22.786 RON;

- Zentiva k.s..receivables to be received from Zentiva SA:        29.412 RON.

 

Please note that the all the amounts mentioned in this current report do not contain VAT.

 

Also we mention that semestrial current reports will be disseminated following the end of each semester in relation to the value of the reported agreements concluded with affiliates, within the prior reported semester.

 

Zentiva SA

Simona Cocos

General Manager



 Print

Information provided by IRIS, the news platform of the Bucharest Stock Exchange.

______________________

Bucharest Stock Exchange ("BVB") is not responsible for the content of this News item. Issuers whose financial instruments are traded on markets operated by BVB are required to report in accordance with current legal and regulatory provisions. BVB publishes these Reports as market administrator, appointed by ASF. When, for investors’ information, Reports are published, either signed by different persons, or with conflicting information, legal liability lies fully with the signatories. BVB disclaims any obligation or responsibility towards issuers or third parties, regarding the reality, completeness and accuracy of information provided by them and distributed by BVB. Website users are responsible for checking content. Any news item (including any prospectus) which is addressed solely to the persons and countries specified therein should not be relied upon other than by such persons and/or outside the specified countries. Terms and conditions, including restrictions on use and distribution apply.


©2016 Bucharest Stock Exchange. All rights reserved